Biomarkers for Lewy body diseases and other alpha-synucleinopathies in biofluids: current evidence and future directions
Abstract Synucleinopathies, including Parkinson’s disease (PD), dementia with Lewy bodies (DLB), and multiple system atrophy (MSA), are a group of proteinopathies characterized by neuronal and glial aggregated alpha-synuclein (α-syn) inclusions. Pathologically, these disorders are typically classifi...
I tiakina i:
| Ngā kaituhi matua: | , , , , , , , , |
|---|---|
| Hōputu: | Artigo |
| Reo: | Inglês |
| I whakaputaina: |
BMC
2025-11-01
|
| Rangatū: | Journal of Translational Medicine |
| Ngā marau: | |
| Urunga tuihono: | https://doi.org/10.1186/s12967-025-07471-6 |
| Ngā Tūtohu: |
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|